Impact of the erythropoietin-derived peptide mimetic Epotris on the histopathological consequences of status epilepticus

Epilepsy Research - Tập 96 - Trang 241-249 - 2011
Christina Zellinger1, Natalie Seeger1, Martin Hadamitzky1, Sarah Fischborn1, Vera Russmann1, Hannes Wendt1, Stanislava Pankratova2, Elisabeth Bock2, Vladimir Berezin2, Heidrun Potschka1
1Institute of Pharmacology, Toxicology, and Pharmacy, Ludwig-Maximilians-University, Koeniginstr. 16, D-80539 Munich, Germany
2Department of Neuroscience and Pharmacology, Protein Laboratory, Panum Institute, University of Copenhagen, Copenhagen N, Denmark

Tài liệu tham khảo

Beccari, 1994, Seizures in dialysis patients treated with recombinant erythropoietin. Review of the literature and guidelines for prevention, Int. J. Artif. Organs, 17, 5, 10.1177/039139889401700102 Becker, 1999, Differential regulation of apoptosis-related genes in resistant and vulnerable subfields of the rat epileptic hippocampus, Brain Res. Mol. Brain Res., 67, 172, 10.1016/S0169-328X(99)00060-1 Brandt, 2006, Treatment with valproate after status epilepticus: effect on neuronal damage, epileptogenesis, and behavioral alterations in rats, Neuropharmacology, 51, 789, 10.1016/j.neuropharm.2006.05.021 Brandt, 2003, Epileptogenesis and neuropathology after different types of status epilepticus induced by prolonged electrical stimulation of the basolateral amygdala in rats, Epilepsy Res., 55, 83, 10.1016/S0920-1211(03)00114-1 Brandt, 2003, N-methyl-d-aspartate receptor blockade after status epilepticus protects against limbic brain damage but not against epilepsy in the kainate model of temporal lobe epilepsy, Neuroscience, 118, 727, 10.1016/S0306-4522(03)00027-7 Buckmaster, 1999, In vivo intracellular analysis of granule cell axon reorganization in epileptic rats, J. Neurophysiol., 81, 712, 10.1152/jn.1999.81.2.712 Chu, 2008, Erythropoietin reduces epileptogenic processes following status epilepticus, Epilepsia, 49, 1723, 10.1111/j.1528-1167.2008.01644.x Couillard-Despres, 2005, Doublecortin expression levels in adult brain reflect neurogenesis, Eur. J. Neurosci., 21, 1, 10.1111/j.1460-9568.2004.03813.x del Rio, 1989, Immunocytochemical detection of 5′-bromodeoxyuridine incorporation in the central nervous system of the mouse, Brain Res. Dev. Brain Res., 49, 311, 10.1016/0165-3806(89)90033-3 Fujikawa, 1996, The temporal evolution of neuronal damage from pilocarpine-induced status epilepticus, Brain Res., 725, 11, 10.1016/S0006-8993(96)00203-X Gouw, 2008, Heterogeneity of white matter hyperintensities in Alzheimer's disease: post-mortem quantitative MRI and neuropathology, Brain, 131, 3286, 10.1093/brain/awn265 Grasso, 2007, Neuroprotection by erythropoietin administration after experimental traumatic brain injury, Brain Res., 1182, 99, 10.1016/j.brainres.2007.08.078 Grasso, 2007, The role of erythropoietin in neuroprotection: therapeutic perspectives, Drug News Perspect, 20, 315, 10.1358/dnp.2007.20.5.1120219 Hasselblatt, 2006, The brain erythropoietin system and its potential for therapeutic exploitation in brain disease, J. Neurosurg. Anesthesiol., 18, 132, 10.1097/00008506-200604000-00007 Humphrey, 2002, Immediate and delayed hippocampal neuronal loss induced by kainic acid during early postnatal development in the rat, Brain Res. Dev. Brain Res., 137, 1, 10.1016/S0165-3806(02)00344-9 Jessberger, 2007, Epigenetic modulation of seizure-induced neurogenesis and cognitive decline, J. Neurosci., 27, 5967, 10.1523/JNEUROSCI.0110-07.2007 Jung, 2004, Continuous cytosine-b–d-arabinofuranoside infusion reduces ectopic granule cells in adult rat hippocampus with attenuation of spontaneous recurrent seizures following pilocarpine-induced status epilepticus, Eur. J. Neurosci., 19, 3219, 10.1111/j.0953-816X.2004.03412.x Jung, 2006, Cyclooxygenase-2 inhibitor, celecoxib, inhibits the altered hippocampal neurogenesis with attenuation of spontaneous recurrent seizures following pilocarpine-induced status epilepticus, Neurobiol. Dis., 23, 237, 10.1016/j.nbd.2006.02.016 Lemstra, 2007, Microglia activation in sepsis: a case–control study, J. Neuroinflammation, 4, 4, 10.1186/1742-2094-4-4 Loscher, 2010, Prevention or modification of epileptogenesis after brain insults: experimental approaches and translational research, Pharmacol. Rev., 62, 668, 10.1124/pr.110.003046 Lykissas, 2007, The role of erythropoietin in central and peripheral nerve injury, Clin. Neurol. Neurosurg., 109, 639, 10.1016/j.clineuro.2007.05.013 Milano, 2005, Erythropoietin and neuroprotection: a therapeutic perspective, J. Oncol. Pharm. Pract., 11, 145, 10.1191/1078155205jp162oa Nadam, 2007, Neuroprotective effects of erythropoietin in the rat hippocampus after pilocarpine-induced status epilepticus, Neurobiol. Dis., 25, 412, 10.1016/j.nbd.2006.10.009 Ndode-Ekane, 2010, Vascular changes in epilepsy: functional consequences and association with network plasticity in pilocarpine-induced experimental epilepsy, Neuroscience, 166, 312, 10.1016/j.neuroscience.2009.12.002 Noguchi, 2007, Role of erythropoietin in the brain, Crit. Rev. Oncol. Hematol., 64, 159, 10.1016/j.critrevonc.2007.03.001 Packard, 1973, Incorporation of thymidine and its analogue, bromodeoxyuridine, into embryos and maternal tissues of the mouse, Differentiation, 1, 397, 10.1111/j.1432-0436.1973.tb00137.x Pankratova, 2010, Neuroprotective properties of a novel, non-haematopoietic agonist of the erythropoietin receptor, Brain, 133, 2281, 10.1093/brain/awq101 Parent, 2006, Aberrant seizure-induced neurogenesis in experimental temporal lobe epilepsy, Ann. Neurol., 59, 81, 10.1002/ana.20699 Pekcec, 2008, Targeting epileptogenesis-associated induction of neurogenesis by enzymatic depolysialylation of NCAM counteracts spatial learning dysfunction but fails to impact epilepsy development, J. Neurochem., 105, 389, 10.1111/j.1471-4159.2007.05172.x Pitkanen, 2009, Molecular and cellular basis of epileptogenesis in symptomatic epilepsy, Epilepsy Behav., 14, 16, 10.1016/j.yebeh.2008.09.023 Racine, 1972, Modification of seizure activity by electrical stimulation. II. Motor seizure, Electroencephalogr. Clin. Neurophysiol., 32, 281, 10.1016/0013-4694(72)90177-0 Scharfman, 2007, Relevance of seizure-induced neurogenesis in animal models of epilepsy to the etiology of temporal lobe epilepsy, Epilepsia, 48, 33, 10.1111/j.1528-1167.2007.01065.x Shapiro, 2008, Structural changes for adult-born dentate granule cells after status epilepticus, Epilepsia, 49, 13, 10.1111/j.1528-1167.2008.01633.x van der Kooij, 2008, Neuroprotective properties and mechanisms of erythropoietin in in vitro and in vivo experimental models for hypoxia/ischemia, Brain Res. Rev., 59, 22, 10.1016/j.brainresrev.2008.04.007 Vezzani, 2008, Innate immunity and inflammation in temporal lobe epilepsy: new emphasis on the role of complement activation, Epilepsy Curr., 8, 75, 10.1111/j.1535-7511.2008.00243.x Vezzani, 1999, Interleukin-1beta immunoreactivity and microglia are enhanced in the rat hippocampus by focal kainate application: functional evidence for enhancement of electrographic seizures, J. Neurosci., 19, 5054, 10.1523/JNEUROSCI.19-12-05054.1999 Walter, 2007, Pilocarpine-induced seizures cause selective time-dependent changes to adult-generated hippocampal dentate granule cells, J. Neurosci., 27, 7541, 10.1523/JNEUROSCI.0431-07.2007 Yang, 2007, Erythropoietin preconditioning suppresses neuronal death following status epilepticus in rats, Acta Neurobiol. Exp. (Warsaw), 67, 141